Clinical Trial Update: Analysis of I-Trace High Order Aberrations Induced by Wavefront Optimized Ablation Profiles [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update evaluating I-Trace high order aberrations induced by wavefront optimized ablation profiles in myopia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Snippet

Sponsor: Alexandria University | Conditions: Myopia | Phase 2, Phase 3 | Status: COMPLETED